Clinical Trial

Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to validate the safety and clinical performance of the ABLE Exoskeleton with integrated Functional Electrical Stimulation (ABLE FES) in individuals with neurological conditions that impair gait, including spinal cord injury, acquired brain injury, and multiple sclerosis. The secondary objective is to collect preliminary data on the potential clinical and psychosocial benefits of combining robotic gait assistance with electrical stimulation.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-04
notable Primary completion pushed: 2026-08-12 -> 2026-09-17 2026-08-04
minor Completion pushed: 2026-08-12 -> 2026-09-17 2026-08-04
Trial Details
NCT Number NCT07550699
Lead Sponsor ABLE Human Motion S.L.
Collaborators: therapy2people GmbH
Conditions Acquired Brain Injury (Including Stroke), Spinal Cord Injury, Multiple Sclerosis
Enrollment 15 participants
Start Date 2026-04-20
Primary Completion 2026-09-17 (estimated)
Study Completion 2026-09-17 (estimated)
Updated on ClinicalTrials.gov 2026-08-03